biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	975709F9-7572-4EB8-ADC2-C60E3BB1A879
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-AAV4-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-AAV4-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-AAV4-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104737
biospecimen__bio__day_of_creation	03
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-G3-AAV4.85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	F
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-G3-AAV4
biospecimen__shared__patient_id	AAV4
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	D40618E3-DA7D-4213-BA39-8CF18CADD46B
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	2.7
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.4
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	4
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.2
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	83
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-AAV4-F65940
clinical__clin_shared__bcr_followup_uuid	10A19B7D-7B09-46EB-A00B-F5EF21339159
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	79
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	1deaec49-bb01-4c7f-b6fe-e25edca28f1a
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-AAV4-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	3de05fe5-6952-4f80-b2e2-b70f7d995e4b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.96
gdc__analytes__analyte_id	94b16f7d-878a-476b-94f4-1aaa029d2973
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	0955d871-5413-4ab2-8fdf-b4feb3aeef5d
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	c9d32e5a-d846-50fe-a8b6-3ae4b6e0f663
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1929
gdc__demographic__year_of_death	2012
gdc__diagnoses__age_at_diagnosis	30466
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-30466.0
gdc__diagnoses__days_to_death	27.0
gdc__diagnoses__diagnosis_id	608356a9-0ac8-576d-998c-715ba29e4e3c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.011176857330703
gdc__exposures__exposure_id	7d25593c-9602-5851-81d9-ea179461b2f8
gdc__exposures__height	156.0
gdc__exposures__weight	56.0
gdc__file_id	a5c42074-421b-47c9-94c0-2f51bdc5453d
gdc__file_name	b5ca2ac1-447b-47af-8481-14ab6b367020.mirbase21.mirnas.quantification.txt
gdc__file_size	50198
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	1408ace6ec4601f38e9f214c29cc1573
gdc__portions__is_ffpe	false
gdc__portions__portion_id	31fb6f4c-d743-4693-9815-5700d91c240c
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	423
gdc__samples__initial_weight	470.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF
gdc__samples__sample_id	076a7d31-e804-4637-b23e-d0e30d32bed4
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	4b37bdcd-8186-4264-9ebf-506ad7d78bbc
gdc__submitter_id	mirna_swap_dr11_149_MirnaExpression8f003b0d-1d69-4dae-8d09-88aca5c734db_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	b1d40e4e-d4d5-5896-8fce-2305e62b0323
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:19.879+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1deaec49-bb01-4c7f-b6fe-e25edca28f1a-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1deaec49-bb01-4c7f-b6fe-e25edca28f1a-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129569
manually_curated__local_md5	775bdf330d9f9aa17714175203790cd6
manually_curated__opengdc_download_date	2018-10-16T17:12:52.000029+02:00
manually_curated__opengdc_file_md5	9b0ad73b36938c2b8683d6d4ea3f573f
manually_curated__opengdc_file_size	50197
manually_curated__opengdc_id	1deaec49-bb01-4c7f-b6fe-e25edca28f1a-meq
manually_curated__origin_file_size	129569
manually_curated__origin_last_modified_date	Tue Oct 16 17:38:00 CEST 2018
manually_curated__origin_md5	775bdf330d9f9aa17714175203790cd6
manually_curated__tissue_status	tumoral
